Replies to post #41241 on Avid Bioservices Inc (CDMO)

[azure107]

Hi sixosix354

I guess this is what I heard from page nine of the
call transcript on seekingalpha. My opinion of what "fully
utilizing" means running 24/7. Which seems like a whole lot
of some kinda little monoclonal antibody buddies are being cranked out considering there is 100L, 300L and 1000L bioreactors. What is your interpretation? Of course I have
no idea of the amount of concentrated, purified, double rectified bavi comes squirting out the end of the still or at what rate the reaction occurs.

"We don’t really provide a lot of projections on our revenues. What I can say is when we look at our backlog of projects coming through, certainly we’re fully utilizing the facility for the foreseeable future, and that’s coming through a mixture of external clients and I would say we want to bring as many external clients as we can into the mix, but also through Peregrine projects and that includes of course making material that supports our own clinical trials that are ongoing, but also making preparations for the next set of studies, and even looking beyond that to eventual potential commercialization of bavituximab, assuming we’re successful in the clinic, we want to be able to commercially manufacture the product here if possible. So, we’re really looking at the business as trying to grow the business from the outside clients; we utilize additional excess capacity for Peregrine projects, again, we’ve reached the point where we’re pretty well fully utilizing our existing capacity as it currently operates. We believe by coming in and just achieving some very attainable optimization of how we use the facility, we can then create additional capacity without actually any or very little additional capital expenditures. So, that’s really our focus, but we think again, with the existing facility, we’re still utilizing of the potential total capacity, probably not more than 60%, and again, I think our goal right now is to realize that additional 40% and then look to building out creating more additional capacity."

[sunstar]

Expansion of Avid; creating revenues of $80 million looks like where they’re going.

Below is a business description of Avid using categorization. When the company, Cotera.com, collected this data, employee numbers were between 10 and 20; revenues over a million but less than five million.

Avid has just hired two new executives, and is hiring eight new technical people. They are, basically doubling staff. To me, this reads that they are, in fact, already in the process of doubling production. Watch for them to, next, move into the expanded adjoining facility.

"AVID BIOSERVICES INC is in the General Contractors Industrial Buildings and Warehouses industry in TUSTIN, CA. This company currently has approximately 10 to 20 employees and annual sales of $1,000,000 to $4,999,999."

http://start.cortera.com/company/research/k3m3qql9l/avid-bioservices-inc/

sunstar